Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

BACKGROUND Cutaneous leishmaniasis (CL) is a world-wide health problem which currently lacks effective, affordable and easy to use therapy. Recently, the meglumine antimoniate (MA) intralesional infiltration was included among the acceptable therapies for New World leishmaniasis. While this approac...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Dario Brock Ramalho, Rosiana Estéfane da Silva, Maria Camilo Ribeiro de Senna, Hugo Silva Assis Moreira, Mariana Junqueira Pedras, Daniel Moreira de Avelar, Lara Saraiva, Ana Rabello, Gláucia Cota
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Fundação Oswaldo Cruz (FIOCRUZ) 2018-06-01
Schriftenreihe:	Memorias do Instituto Oswaldo Cruz
Schlagworte:	intralesional infiltration meglumine antimoniate cutaneous leishmaniasis therapy
Online-Zugang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762018000900300&lng=en&tlng=en
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!